Toray Industries, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Toray Industries, Inc. – Product Pipeline Review – 2016’, provides an overview of the Toray Industries, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Toray Industries, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Toray Industries, Inc.

The report provides overview of Toray Industries, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Toray Industries, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Toray Industries, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Toray Industries, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Toray Industries, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Toray Industries, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Toray Industries, Inc. Snapshot 5

Toray Industries, Inc. Overview 5

Key Facts 5

Toray Industries, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Toray Industries, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products - Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Toray Industries, Inc. - Pipeline Products Glance 14

Toray Industries, Inc. - Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Toray Industries, Inc. - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Toray Industries, Inc. - Drug Profiles 17

beraprost sodium ER - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

GT-0198 - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

HIS-388 - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

Small Molecule to Agonize Prostacyclin Receptor for Bleeding and Clotting Disorders - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Small Molecule to Antagonize Alpha1B Adrenoceptor - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

Small Molecule to Antagonize CCR3 for Undisclosed Indication - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Small Molecule to Block TRPV1 for Overactive Bladder - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

Small Molecules to Antagonize mGluR5 for Anxiety - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

Small Molecules to Inhibit Dipeptidyl Peptidase IV for Type 2 Diabetes - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

Small Molecules to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

TRK-390 - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

TRK-700 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

Toray Industries, Inc. - Pipeline Analysis 30

Toray Industries, Inc. - Pipeline Products by Target 30

Toray Industries, Inc. - Pipeline Products by Route of Administration 31

Toray Industries, Inc. - Pipeline Products by Molecule Type 32

Toray Industries, Inc. - Pipeline Products by Mechanism of Action 33

Toray Industries, Inc. - Dormant Projects 34

Toray Industries, Inc. - Discontinued Pipeline Products 35

Discontinued Pipeline Product Profiles 35

beraprost sodium SR 35

TAK-363 35

Toray Industries, Inc. - Company Statement 36

Toray Industries, Inc. - Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Appendix 42

Methodology 42

Coverage 42

Secondary Research 42

Primary Research 42

Expert Panel Validation 42

Contact Us 42

Disclaimer 43

List of Tables

List of Tables

Toray Industries, Inc., Key Facts 5

Toray Industries, Inc. – Pipeline by Indication, 2016 7

Toray Industries, Inc. – Pipeline by Stage of Development, 2016 8

Toray Industries, Inc. – Monotherapy Products in Pipeline, 2016 9

Toray Industries, Inc. – Partnered Products in Pipeline, 2016 10

Toray Industries, Inc. – Partnered Products/ Combination Treatment Modalities, 2016 11

Toray Industries, Inc. – Out-Licensed Products in Pipeline, 2016 12

Toray Industries, Inc. – Out-Licensed Products/ Combination Treatment Modalities, 2016 13

Toray Industries, Inc. – Phase II, 2016 14

Toray Industries, Inc. – Preclinical, 2016 15

Toray Industries, Inc. – Discovery, 2016 16

Toray Industries, Inc. – Pipeline by Target, 2016 30

Toray Industries, Inc. – Pipeline by Route of Administration, 2016 31

Toray Industries, Inc. – Pipeline by Molecule Type, 2016 32

Toray Industries, Inc. – Pipeline Products by Mechanism of Action, 2016 33

Toray Industries, Inc. – Dormant Developmental Projects,2016 34

Toray Industries, Inc. – Discontinued Pipeline Products, 2016 35

Toray Industries, Inc., Other Locations 37

Toray Industries, Inc., Subsidiaries 38

List of Figures

List of Figures

Toray Industries, Inc. – Pipeline by Top 10 Indication, 2016 7

Toray Industries, Inc. – Pipeline by Stage of Development, 2016 8

Toray Industries, Inc. – Monotherapy Products in Pipeline, 2016 9

Toray Industries, Inc. – Pipeline by Top 10 Target, 2016 30

Toray Industries, Inc. – Pipeline by Route of Administration, 2016 31

Toray Industries, Inc. – Pipeline by Molecule Type, 2016 32

Toray Industries, Inc. – Pipeline Products by Top 10 Mechanism of Action, 2016 33

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports